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INTRODUCTION
Moraxella catarrhalis is an aerobic, Gram-negative diplococcal commensal of the respiratory tract. Although healthy children are frequently colonized with this bacterium, it is also able to cause disease, being especially associated with otitis media (OM), as well as exacerbations of chronic obstructive pulmonary disease (COPD) in adults.
Studies have shown that the bacterium colonizes the nasopharynx soon after birth and that the carriage rate of M. catarrhalis in healthy children may differ per geographical region, season and year of isolation [1] . For example, in a German study (November 1991 to April 1992), 9% of children attending day-care centers ranging in age from 4 months to 3 years old were colonized with M. catarrhalis [2] . In a Japanese study conducted in 1999, children aged 1 month to 5 years attending day-care centers, 35% were found to be colonized [3] . In The Netherlands, a comparative study of 1.5 to 14 month old children born between February 2003 and August 2005, indicated a carriage rate for children ranging from 11.8% at the age of 1.5 months to 29.9% at the age of 6 months and 29.7% at the age of 14 months [4] . In general, despite local geographical variation, infants tend to become colonized with M. catarrhalis at a very early age, resulting in a nasopharyngeal colonization peak for M. catarrhalis at 2 years of age [5] .
Bacterial adherence to the respiratory mucosa is an essential step towards colonization of the human respiratory tract epithelium, and research has indicated that the most important adhesins responsible for the attachment of M. catarrhalis to host cells include the outer membrane proteins (OMPs) UspA1, UspA2 and Hag/MID, though several other surfaceexposed outer membrane proteins have been described that may also play a role in the process. Further, with respect to M. catarrhalis, it has been shown that colonization of the human respiratory tract epithelium results in an increased risk of disease, specifically OM disease (both chronic and acute) in children [6] [7] . Further, two distinct genetic lineages related to 3 different 16S rRNA types have been identified for M. catarrhalis, which differ phenotypically in their ability to resist the killing effect of human serum (sero-resistant versus sero-sensitive), and in their ability to adhere to human epithelial cells [8] [9] . Therefore, it is reasonable to expect that an effective immune response raised against UspA1, UspA2 and Hag/MID, for example via vaccination, will have a significant effect on colonization and disease.
OM is one of the major childhood diseases that necessitate visits to general practitioners [10] . In 2004, the American Academy of Pediatrics (AAP) published new guidelines that addressed the diagnosis and treatment of acute otitis media (AOM), largely because the treatment of AOM is not always appropriate, and the long-term overuse of antibiotics increases the risk of the development of antimicrobial resistance. The AAP guidelines recommended the use of observation as a potential strategy for the treatment of AOM, although global rates of antibiotic prescription for AOM still vary greatly [11] [12] [13] .
An alternative strategy to the use of antibiotics in the treatment of OM disease is vaccination [14] . However, there is currently no licensed vaccine available against M.
catarrhalis, and none of the antigens so far described (which may serve as potential vaccine candidates) have progressed to clinical trials. The challenge in identifying potential vaccine candidates for M. catarrhalis lies in identifying antigens that are able to generate an appropriate immune response that prevents the process leading from colonization to infection, and are conserved among global strains [15] . It is known that healthy adults possess naturally acquired serum antibodies directed against several M. catarrhalis OMPs, apparently via the acquisition and elimination of many different M. catarrhalis strains [16] . Further, changes in antibody response are observed in adults suffering from M. catarrhalis-mediated COPD disease [17] . [16, [20] [21] [22] [23] [24] . These 9 recombinant proteins (from 7 different OMPs) represented the majority of published M.
catarrhalis immunogenic proteins discovered at the time that the study was initiated. Further, the relationship between M. catarrhalis colonization and humoral immune response was also investigated.
MATERIALS AND METHODS

Study cohort
This study was embedded in the Generation R Study, a population-based prospective cohort study, designed to identify early environmental and genetic causes of normal and abnormal growth, development and health from fetal life until young adulthood [25] . This respectively. The colonization status was determined using standard M. catarrhalis culture and detection techniques [1] .
Moraxella catarrhalis antigens
The and orf296 were used in this study [16, [20] [21] [22] [23] [24] . These 9 recombinant proteins (from 7 different OMPs) represented the majority of published M. catarrhalis immunogenic proteins discovered at the time that the study was initiated, and are derived from the reference M. ) [16, 20, 22, 26] . Orf238 and orf296 are hypothetical proteins that share homology with lipoprotein family A proteins and with the M. osloensis disulfide isomerase gene, which encodes a virulence factor, respectively.
Antigen coupling
Recombinant proteins were coupled to SeroMAP TM beads, which are carboxylated The microspheres were protected from light and stored at 4°C until required. All centrifugation steps were performed at 12,000 g for 2 min at room temperature (RT).
Uncoupled beads were used as a negative control, and to determine non-specific binding. If minor non-specific binding was observed, then the median fluorescence intensity (MFI) values obtained from this non-specific binding was subtracted from the antigenspecific results.
Multiplex M. catarrhalis antibody assay
The multiplex procedure was performed as described elsewhere [27] . Briefly, after used [19] . The uspA2, uspA2H and uspA1 screening primers are situated at the 3'-end of the respective genes, whilst the hag/mid primers amplify a region at the 5'-end of the gene, including a small region of the promotor.
Further, PCR was performed to detect 16S rRNA types as previously described by Verhaegh et al. (2008) [19] .
To identify the 16S rRNA types of individual M. catarrhalis isolates, 16S rRNA PCR products were digested using the enzymes FspBI (10 U) and HhaI (10 U) according to Verhaegh et al. (2008) [19] . seconds during the first 12 hours, followed by a 2nd block of 8 hours where the pulse time increased linearly from 1 to 5 seconds. All PFGE patterns were analyzed using BioNumerics (Applied Maths), with gel lanes normalized against a lambda DNA ladder (Bio-Rad) and band tolerance set to 1.5%. PFGE products between 48.5 and 339.5 kb were included in the band matching analysis.
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Statistical analysis
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Statistical analyses were performed using SPSS PASW 17.0.2. The Wilcoxon signedrank test was used to compare the anti-Moraxella antibody levels between different age groups. The Mann-Whitney U-test was used to compare differences in antibody levels between colonized and non-colonized children. A P-value of ≤0.05 was considered to be statistically significant.
RESULTS
Isolate genotyping and vaccine candidate gene carriage
A high degree of genotypic heterogeneity in M. catarrhalis isolates colonizing children in the focus cohort was maintained over the entire study period, with no association found between genotype and any of the antigen-specific MFI values. In total, 28 different genotypes were observed, with only two children being colonized more than once (Fig. 1 ). Table 1) .
Dynamics of the anti-Moraxella antibody response
The changes measured in anti-M. catarrhalis IgG, IgA and IgM during the first 2 years of life are shown in Fig. 2 In total, 9 (33%), 10 (24%) and 11 (29%) of the children were found to be colonized with M. catarrhalis at the time of sampling at 6, 14 and 24 months, respectively. There was no significant difference in IgG levels for all antigens between colonized and non-colonized children, except for MID 962-1200 at 24 months of age (P=0.04) (Fig. 3) . Further, the increase in (Fig. 4) .
DISCUSSION
The research performed in this publication represents the most extensive study of the infant immune response to potential vaccine candidates of M. catarrhalis performed to date, utilizing 9 recombinant domains representing 7 different M. catarrhalis OMPs in a cohort of 57 healthy children followed from birth until 2 years of age. Further, the study was performed using multiplexed Luminex"s xMAP technology that proved to be a rapid method for research into humoral immune response changes during M. catarrhalis colonization.
In our study, the level of antigen-specific IgG to M. catarrhalis antigens in cord blood was significantly higher compared to the anti-M. catarrhalis IgG level at 6 months, most likely due to the presence of maternally derived IgG antibodies that were transferred to the fetus through the placenta. The passage of antibodies between mother and baby, via the umbilical cord, gives rise to "passive immunity", which generally tends to confer humoral protection against infection until approximately 6 months after birth [30] . During this 6 month period, passively acquired antibodies disappear and are replaced by antibodies generated by the infants" own "actively acquired" humoral immune response. This actively acquired immune response may be generated by successive rounds of colonization and/or infection by pathogens, leading to the development of a host-specific immune response and eventual pathogen clearance. In this respect, Ejlertsen et al. (1994) showed a significant fall in antibody concentration during the first 3 months of life, and a steady low level was maintained in the age group from 3 to 10 months, similar to the results obtained in this study [31] . Further, from the age of 1 year, the immune response of the children in the study of healthy adults and adults suffering from COPD. It is also found in small amounts in blood [32] . This may explain the relatively low levels of IgA found in this study, as serum antigenspecific IgA levels were measured and not secretory IgA [33] [34] .
The IgM levels to all 7 OMPs were also relatively low throughout the study period.
IgM antibodies appear early in the course of an infection and usually reappear, to a lesser extent, after further exposure. In contrast to IgG, IgM (and also IgA) antibodies do not pass across the human placenta.
Though an antibody response was generated against our M. catarrhalis OMP vaccine candidates in our focus cohort group during the first 2 years of life, the relatively constant All authors declare that they have no conflicts of interest. 
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